HOLKIRA

Swiss trademark · 657658 · Word mark · Deleted

Register entry

Registration number
657658
Application number
51118/2014
Status
Deleted
Type
Word mark
Filed
Jan 29, 2014
Registered
Apr 22, 2014
Published
Apr 22, 2014
Deleted
Aug 22, 2024
Reason
Not renewed
Priority
15.08.2013 US
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate zur Behandlung von Hepatitis C.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 22, 2024

    Deleted, not renewed

    Status of protective title
    Active → Cancelled
    Cancellation date
    22.08.2024
    Cause for cancellation
    Cancellation due to non-renewal

    Published in Swissreg on 22.08.2024

  2. Jan 15, 2024

    Corrected

    Owner
    AbbVie Manufacturing Management Unlimited Company, 70 SirJohn Rogerson¿s Quay, Dublin 2, Ireland → AbbVie Manufacturing Management Unlimited Company, 70 Sir John Rogerson's Quay, Dublin 2, Ireland
    Representative
    Baker McKenzie Zurich, Holbeinstrasse 30, Postfach, 8034 Zürich → Baker McKenzie Switzerland AG, Holbeinstrasse 30, 8034 Zurich

    Published in Swissreg on 15.01.2024

  3. Jan 12, 2024

    Agent removed

    Representative
    Baker & McKenzie Zurich, Holbeinstrasse 30, 8034 Zürich (removed)

    Published in Swissreg on 12.01.2024

  4. Jan 12, 2024

    Transferred

    Owner
    AbbVie Ireland Unlimited Company, 2 Church Street, Hamilton HM 11, Bermuda → AbbVie Manufacturing Management Unlimited Company, 70 SirJohn Rogerson¿s Quay, Dublin 2, Ireland
    Representative
    Baker McKenzie Zurich, Holbeinstrasse 30, Postfach, 8034 Zürich

    Published in Swissreg on 12.01.2024

  5. Jan 30, 2019

    Transferred

    Owner
    AbbVie Inc., 1 North Waukegan Road, North Chicago, IL 60064, USA → AbbVie Ireland Unlimited Company, 2 Church Street, Hamilton HM 11, Bermuda

    Published in Swissreg on 30.01.2019

  6. Mar 17, 2015

    Partly deleted

    LGS
    5, Pharmazeutische Präparate und Substanzen zur Behandlung von viralen, metabolischen, endokrinen, muskuloskelettalen, kardiovaskulären, kardiopulmonalen, urogenitalen, onkologischen, hepatologischen, ophthalmischen, respiratorischen, neurologischen, gastrointestinalen, hormonellen, dermatologischen, psychiatrischen und das Immunsystem sowie sexuelle Dysfunktion betreffenden Erkrankungen und Störungen; Impfstoffe. → 5, Pharmazeutische Präparate zur Behandlung von Hepatitis C.
    International classification
    5 → 5

    Published in Swissreg on 17.03.2015

  7. Apr 22, 2014

    Registered

    Published in Swissreg on 22.04.2014

Parties

Holder

AbbVie Manufacturing Management Unlimited Company

70 Sir John Rogerson's Quay, Dublin 2, IE

Agent

Baker McKenzie Switzerland AG

Holbeinstrasse 30, 8034 Zurich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.